Rutgers Biomedical and Health Sciences (RBHS)

Fingerprint Dive into the research topics where Rutgers Biomedical and Health Sciences (RBHS) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Maha Abdellatif

    Maha Abdellatif

    Person

    19862019
    No photo of Elizabeth Abercrombie

    Elizabeth Abercrombie

    Person

    19832018
    Photo of Victoria Abraira

    Victoria Abraira

    Person

    20062019

    Projects

    Impact of mutation burden on cancer growth and the immune landscape

    Ganesan, S., Lattime, E. & White, E.

    National Institutes of Health

    12/1/19 → 11/30/24

    Project: Research project

    • Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins

    Woychik, N.

    National Institutes of Health

    12/1/19 → 11/30/24

    Project: Research project

    • PPAR? induces IL-6 to trigger diabetic cardiomyopathy

    Sadoshima, J.

    National Institutes of Health

    12/1/19 → 11/30/23

    Project: Research project

    • Research Output

    High Acuity of Postoperative Consults to Emergency General Surgery at an Urban Safety Net Hospital

    Fiorentino, M., Mulles, S., Cue, L., Merchant, A. M., Tufariello, A., Cummings, D., Onwubalili, K. & Glass, N. E., Jan 2021, In : Journal of Surgical Research. 257, p. 50-55 6 p.

    Research output: Contribution to journal › Article

    • (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells

    Wu, P., Wang, X., Ma, Y., Xu, X., Liu, W., Sheng, Z., Chen, M., Zhou, R., Zhang, K., Goodin, S., Zheng, X. & Li, D., Aug 2020, In : Bioorganic Chemistry. 101, 104022.

    Research output: Contribution to journal › Article

    • 18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

    Lim, I., Lindenberg, M. L., Mena, E., Verdini, N., Shih, J. H., Mayfield, C., Thompson, R., Lin, J., Vega, A., Mallek, M., Cadena, J., Diaz, C., Mortazavi, A., Knopp, M., Wright, C., Stein, M., Pal, S., Choyke, P. L. & Apolo, A. B., Jan 1 2020, In : European Journal of Nuclear Medicine and Molecular Imaging. 47, 1, p. 178-184 7 p.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations